Supplementary Table 5 from BET Bromodomain Inhibition of <i>MYC</i>-Amplified Medulloblastoma
Pratiti Bandopadhayay(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Yoon‐Jae Cho(Broad Institute), Sabran Masoud(Broad Institute), William J. Gibson(Broad Institute), Brian T. Nguyen(Los Angeles Medical Center), Rameen Beroukhim(Broad Institute), Sara Bolin(Uppsala University), Samuel Cheshier(Primary Children's Hospital), Mark W. Kieran(Children Cancer Hospital), Sharareh Gholamin(Institut de génétique et de développement de Rennes), Yujie Tang(Shanghai Jiao Tong University), Robert J. Wechsler‐Reya(Columbia University Irving Medical Center), Fredrik J. Swartling(Uppsala University), Jun Qi(Georgia Institute of Technology), William A. Weiss(City College of San Francisco), Guillaume Bergthold(Roche (Switzerland)), Steven E. Schumacher(Broad Institute), Brenton R. Paolella(Broad Institute), Rhamy Zeid(C4 Therapeutics (United States)), Furong Yu(Broad Institute), Simone Schubert(Stanford University), Nujsaubnusi Vue(Broad Institute), Siddhartha Mitra, James E. Bradner(Novartis (China)), Kun-Wei Liu
Cited by 0
Related Papers
Comprehensive molecular profiling of lung adenocarcinoma
|Nature|2014|5.9k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k